Indeed, previous studies employing Hif2a haploinsufficient mice have shown that these mice are also protected against hypoxia-induced pulmonary hypertension, but not hypoxia-induced erythrocytosis (Brusselmans et al. 2003; Hodson et al. 2016). This evidence concerns the gene EPAS1 and pulmonary arterial hypertension.